• Aucun résultat trouvé

Lipoprotein Metabolism in Familial Hypercholesterolemia

N/A
N/A
Protected

Academic year: 2021

Partager "Lipoprotein Metabolism in Familial Hypercholesterolemia"

Copied!
38
0
0

Texte intégral

Loading

Figure

Figure 2 Liver cell Extracellular Space§LDL binding assayClass 3Binding defective§LDLR expression and LDL uptake by flow cytometry§Confocal microscopy§Western BlotClass 2Transport defective§LDLR expression and LDL uptake by flow cytometry§Western BlotClass

Références

Documents relatifs

tinine serait plus sensible que celle du DFG pour détec- ter la NPC, mais la corrélation clinique de cette variation d’incidence reste à évaluer. En effet, près de la moitié

iens, due to technical restrictions and the amplifications of this gene in the Wolbachia harboured by this species, we investigated here the putative link between CI mod

Thus, the localization of the B4GALNT2 gene within the minimal locus, the presence of the SNP g.36938224T.A on OAR11, localized in the intron 7 of this gene as the possible

Plasma apolipoprotein E (apo E) and apolipoprotein(a) levels were measured by liquid chromatography–tandem mass spectrometry in plasma samples isolated from 444 nontreated patients

Although no sign of cell apoptotis was observed at the time of implantation of the cell constructs, the number of TUNEL positive cells increased at day 6 post-implantation, peaked

The novel LDLR gene mutation identified in this family, 756del7, induces a frameshift with creation of a stop codon at position 241 and it would cause a class 1 LDL receptor

Our results thus confirm the value of salvage therapy based on foscarnet plus AZT, 4,5 in patients selected for their overall resistance profile and not for the number of TAMs, and

Results: We identified three novel mutations (C25X, IVS3+5G>T, D558A) and two mutations previously described (D151N, A480E) in the LDLR gene.. The R3500Q and R3531C mutations